ZPD A/S: Financial statements 2021
CVR: 32834825
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ZPD A/S (CVR 32834825) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 35,200,000 and a net result of DKK 6,963,000 compared with DKK 5,954,000 the year before. That is a decrease of 1% compared with the year before. Equity in the 2021 report amounted to DKK 178,166,000. The solvency ratio was 94%. The company had 36 employees in the financial year.
- Gross Profit
- DKK 35,200,000
- Profit/Loss
- DKK 6,963,000
- Equity
- DKK 178,166,000
- Total Assets
- DKK 189,620,000
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 35.2 mio. | 7 mio. | 178.2 mio. | 36 |
| 2020 | - | 35.6 mio. | 6 mio. | 171.2 mio. | 34 |
| 2019 | - | 36.8 mio. | 7.7 mio. | 165.2 mio. | 33 |
| 2018 | - | 41.5 mio. | 11.4 mio. | 157.5 mio. | 32 |
| 2017 | - | 40.8 mio. | 11.2 mio. | 146.1 mio. | 28 |
Official annual report
Find more companies like ZPD A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 31, 2021, Ryu Nakao has stepped down as director of ZPD A/S.
As of July 12, 2021, Kenichi Suzuki has joined the board of directors of ZPD A/S.
As of July 12, 2021, Ken Motegi has left the board of directors of ZPD A/S.
ZPD A/S has published its annual report for 2020. Gross profit came to DKK 35,568,000, and the net result was DKK 5,954,000.
As of April 22, 2021, Ken Motegi has joined the board of directors of ZPD A/S.
As of April 22, 2021, Yoshihiro Hiraga has left the board of directors of ZPD A/S.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.